Pages that link to "Q35873186"
Jump to navigation
Jump to search
The following pages link to Modulation by prednisolone of calcium handling in skeletal muscle cells. (Q35873186):
Displaying 25 items.
- Corticosteroids for the treatment of Duchenne muscular dystrophy (Q24185788) (← links)
- Glucocorticoid corticosteroids for Duchenne muscular dystrophy (Q24242199) (← links)
- Glucocorticoid corticosteroids for Duchenne muscular dystrophy (Q24247197) (← links)
- Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts (Q24629251) (← links)
- Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy (Q24644090) (← links)
- Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid (Q28544401) (← links)
- Dystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel Therapies (Q33608478) (← links)
- Characteristics of skeletal muscle in mdx mutant mice (Q33644573) (← links)
- Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase A(2)-dependent mechanism. (Q33840413) (← links)
- Muscular response to the first three months of deflazacort treatment in boys with Duchenne muscular dystrophy (Q33856905) (← links)
- Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy (Q34489678) (← links)
- Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG). (Q34807183) (← links)
- Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells (Q35027943) (← links)
- Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress (Q35873884) (← links)
- Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy (Q38887550) (← links)
- Calcium homeostasis and glucose uptake of murine myotubes exposed to insulin, caffeine and 4-chloro-m-cresol (Q40688311) (← links)
- Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research (Q44121924) (← links)
- Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. (Q46887832) (← links)
- RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion (Q50977301) (← links)
- Quantitative and qualitative adaptations of muscle fibers to glucocorticoids. (Q51309321) (← links)
- Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation. (Q54596150) (← links)
- Creatine supplementation improves intracellular Ca2 handling and survival in mdx skeletal muscle cells (Q58829497) (← links)
- Efficacy of Prednisolone in Generated Myotubes Derived From Fibroblasts of Duchenne Muscular Dystrophy Patients (Q60047620) (← links)
- Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers (Q74583809) (← links)
- The effect of methylprednisolone on intracellular calcium of normal and dystrophic human skeletal muscle cells (Q78076761) (← links)